Schedule 13G ownership disclosure

MATINAS BIOPHARMA HLDGS INC

Common Stock, par value $0.0001 per share · CUSIP: 576810303

Event date: 2025-06-30

Filing-level shares
466,667.00
Percent of class
8.4%
  • Highbridge Capital Management, LLC

    Shares: 466,667.00 · Class: 8.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-003632
Form type
SCHEDULE 13G/A
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub